Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study Initiations (BHVN)

· seekingalpha.com

Biohaven (BHVN) upgraded to Buy on FDA shifts and strong biomarker data.

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI